NCT00551889View on ClinicalTrials.gov

Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

celecoxib

DRUG

cyclophosphamide

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00551889 - Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter